Annual Meeting of PSSLD

Pakistan Society for the Study of Liver Diseases

Friday, November 30, 2007
Inauguration session
Registration	Starts at 1800 hrs
Inauguration, Dinner symposium	1900 hrs
Dinner	2000 hrs

CORE MEETING

Saturday, December 1, 2007
Session 1 9:00 - 1010 Preventative Hepatology
HBV in the EPI program in Pakistan: Success?	10’
Vertical transmission of HBV: Is it our problem?	10'
Prevention of HCV: Blood banking practices	10'
Hepatitis A Vaccination: Strategies for Pakistan	10'
Prevention of Noscomial Hepatitis B & C	10'
Discussion and Panel Recommendations: Critical measures for prevention of viral hepatitis in Pakistan	20'

Tea: 1010 - 1030

Session 2 1030 - 1200 Hepatitis B
Role of HBV DNA Quantification and liver biopsy	10’
Management of HBeAg positive patient	10'
Management of HBeAg negative patient	10'
What to do for the HDV co-infected patient	10'
Discussion:	20'
State of Art Lecture Hepatitis B: Emerging Therapies!	20'
Panel Discussion: Recommendations for the Treatment of HBV in South Asia in light of APASL Guidelines	30'
1200 - 1300 Lunch Symposium Chronic Hepatitis B
Treatment options in the new Millennium	20'
Resistance issues: From diagnosis to management	20'
Discussion and Q&A:	10'

1300 - 1345 - Lunch & Prayer Break

Session 3 1345 - 1525 Hepatitis C
Relevance of Quantitative PCR and liver biopsy in HCV	10’
Treatment of naïve HCV patients	10'
Treatment of relapsers/ non-responders	10'
Treatment of Acute Hepatitis C	10'
HCV-HIV co-infected: How to treat?	10'
State of Art Lecture Future Directions in HCV management!	30'
Panel Discussion: Recommendations for the treatment of HCV in South Asia in light of current guidelines	20'

Tea: 1525 - 1545

Session 4 1545 - 1705 Management of Hepatocellular Carcinoma
Screening of HCC; Who and How	10’
Role of radiologist in the diagnosis and treatment of HCC	10'
Resection/ transplantation in HCC	10'
Management of advanced HCC	10'
Panel Discussion:	20'
State of Art Lecture Future prospects in the management of HCC!	20'
1830 - 1920 Dinner Symposium
Hepatitis C treatment in special circumstances	30'
Discussion and Q&A	20'

1930 - Dinner

Sunday, December 2, 2007
Session 5 9:00 - 1010 NASH
Etio-pathogenesis of NAFLD	10’
Insulin resistance and liver diseases	10'
Histologic features of Hepatic Steatosis	10'
Management of NASH in 2007	10'
Panel Recommendations:	20'

Session 6
1000 - 1115
Free Paper Session
Parallel Poster Presentation Session

Six selected papers for oral presentation and best presentation award

Tea Break - 1115 - 1130

Session 7 1130 - 1240 Portal Hypertension
Should we endoscope all cirrhotics for varices?	10’
Measurement of HVPG: Is it necessary/is it practical?	10'
Primary and secondary prophylaxis for gastric varices	10'
Management of portal hypertensive gastropathy	10'
Refractory ascites: TIPS vs Paracentesis	10'
Panel Discussion and Recommendations: In accordance with Baveno IV	20'
1240 - 1320 Lunch Symposium
Portal Hypertension: From pathogenesis to management	30'
Discussion and Q&A	10'

Lunch

:: Top ::